Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Quarterly Basic Net EPS At 2016-03-31

0

For the year ended 2016-03-31 Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic consolidated EPS came $-1.4765. Conversely, for the quarter ended 2016-03-31, it was $-1.4765.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) EPS from continuing operations was $-1.4765 for the fiscal ended 2016-03-31. For the quarter ended 2016-03-31, this figure was $-1.4765.

EPS contribution from parent

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) confirmed basic EPS of $-1.4765 for the year ended 2016-03-31 from its parent group. Conversely, for the quarter closed 2016-03-31 it was $-1.4765.

Basic net EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic net EPS was $-0.06 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it came at $-0.06.

Consolidated diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) consolidated diluted EPS was -1.4765 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it stood at $-1.4765.

Basic diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic diluted EPS was $-0.0625 for the quarter ended 2016-03-31. For the year ended 2016-03-31, basic diluted EPS was $-0.0625.

Net diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) posted net diluted EPS of $-1.48 for the fiscal closed 2016-03-31. For the quarter ended 2016-03-31, net diluted EPS was $-1.48.

Diluted EPS from parent

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) diluted EPS from parent group was $-1.4765 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $-1.4765.

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) net basic EPS was $-1.4288 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it was $-1.4288.

For the year ended 2016-03-31, basic shares outstanding were 32.865 while for the quarter ended 2016-03-31 is 32.865.

For the fiscal ended 2016-03-31, the diluted outstanding shares were 32.865 and for the quarter ended 2016-03-31 it was 32.865.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 5 times, 1 visits today)